Skip to search formSkip to main contentSkip to account menu

Geroxalen

Known as: Methoxsalen Sanofi-Synthelabo Brand, Sanofi Synthelabo Brand of Methoxsalen, Sanofi-Synthelabo Brand of Methoxsalen 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Fingolimod is the first orally administered drug approved for the treatment of relapsing–remitting multiple sclerosis (MS). This… 
Review
2018
Review
2018
Tandem mass spectrometry (MS/MS) is a highly sensitive and specific technique. Thanks to the development of triple quadrupole… 
Review
2017
Review
2017
Purpose More research into the psychosocial aspects of diabetes is needed so that the health and quality of life of people with… 
Review
2013
Review
2013
I nherent in deDuve’s original concept of the lysosome was the need for intracellular mechanisms to localize, deliver, or traffic… 
2011
2011
Background: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) wane after early… 
2009
2009
The induction of persistent protective levels of pathogen‐specific antibody is an important goal of immunization against… 
2006
2006
We report a patient who had a history of deep vein thrombosis in a previous pregnancy. She was treated with heparins without any… 
Highly Cited
2005
Highly Cited
2005
In a recent study, EF1502 [N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-hydroxy-4-(methylamino)-4,5,6,7-tetrahydrobenzo [d…